Literature DB >> 7554249

Abnormal trace elements in a patient on total parenteral nutrition with normal renal function.

F Y Leung1, D M Grace, M A Alfieri, C Bradley.   

Abstract

OBJECTIVE: To describe trace metal changes in a 74-year-old male patient with mesenteric fibrosis and a small bowel fistula who was maintained on total parenteral nutrition in the hospital and at home.
METHODS: Trace elements which included chromium and selenium were monitored over a 14-month period as part of his nutrient follow-up.
RESULTS: Serum chromium reached levels > 21-fold the upper reference range, and serum selenium, in contrast, was < 0.5 the lower reference range. Plasma aluminum was also measured, and found to be nearly twice the upper reference range, although the patient had normal renal function. We measured the aluminum content of the parenteral nutrients and additives, and found that replacement of calcium gluconate by calcium chloride helped to reduce the aluminum content in the final parenteral solution by 34%. Aluminum and chromium contaminants found in parenteral solutions need to be reduced or removed to avoid toxic accumulation.
CONCLUSION: This study illustrates the importance of adequately adjusting essential trace elements, and monitoring contaminants in parenteral fluids in an individual on total parenteral nutrition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554249     DOI: 10.1016/0009-9120(95)00001-p

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  2 in total

1.  Characterization and Separation Performance of a Novel Polyethersulfone Membrane Blended with Acacia Gum.

Authors:  Yehia Manawi; Viktor Kochkodan; Ebrahim Mahmoudi; Daniel J Johnson; Abdul Wahab Mohammad; Muataz Ali Atieh
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

Review 2.  Parenteral trace element provision: recent clinical research and practical conclusions.

Authors:  P Stehle; B Stoffel-Wagner; K S Kuhn
Journal:  Eur J Clin Nutr       Date:  2016-04-06       Impact factor: 4.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.